Related Experiment Videos
dl-alpha-Tocopheryl acetate induces hypocoagulability and platelet hypoaggregability in rats.
M L Díez Marques1, F J Lucio Cazaña, M Rodringuez Puyol
1Physiology and Pharmacology Department, Alcalá de Henares University, Spain.
Summary
Vitamin E (dl-alpha-tocopheryl acetate) supplementation in rats reduced platelet aggregation and prolonged clotting times. This suggests vitamin E may help manage hypercoagulable states.
Area of Science:
- Biochemistry
- Pharmacology
- Hematology
Background:
- Platelet aggregation and coagulation are critical hemostatic processes.
- Dysregulation of these processes can lead to thrombotic or bleeding disorders.
- Vitamin E is a known antioxidant with potential effects on cellular function.
Purpose of the Study:
- To investigate the effects of dl-alpha-tocopheryl acetate on platelet aggregation and coagulation in rats.
- To determine if vitamin E supplementation influences key hemostatic parameters.
Main Methods:
- Rats received daily intraperitoneal injections of dl-alpha-tocopheryl acetate (50 mg/kg) for 4 days.
- Platelet aggregation was induced by adenosine diphosphate (ADP) or adrenaline.
- Thromboelastography was performed on platelet-rich and platelet-poor plasma.
- Serum biochemical parameters were analyzed.
Main Results:
- Plasma alpha-tocopherol levels were slightly increased in treated rats.
- Platelet aggregation induced by ADP or adrenaline was significantly decreased.
- Thromboplastin formation times were significantly higher in treated rats.
- Minor modifications were observed in other serum biochemical parameters.
Conclusions:
- Vitamin E (dl-alpha-tocopheryl acetate) significantly inhibits platelet aggregation and delays coagulation in rats.
- These findings suggest a potential therapeutic role for vitamin E in managing hyperaggregable and hypercoagulable conditions.